Abstract: A composition including a first compound capable of functioning as a phosphorescent emitter in an OLED is provided. The first compound has at least one aromatic ring and at least one substituent R directly bonded to one of the at least one aromatic rings. Each substituent R has the formula of where (a) G1 is selected from NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; and G2 is a non-aromatic polycyclic group; (b) G1 is a direct bond; and G2 is a non-aromatic spiro polycyclic group; or (c) G1 is selected from direct bond, NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; G2 is a non-aromatic polycyclic group; and R is directly bonded to a phenyl, pyridine, or triazine. R1, R2, and R3 are are a variety of substituents. Formulations and devices, such as an OLEDs, that include the first compound are also described.

Abstract: A compound of Formula Ir(LA)x(LB)y(LC)z is provided, where x is 1 or 2, each of y and z is 0, 1, or 2, at least one of y and z is not 0, and x+y+z=3. Ligand LA has a structure of Formula I, where LB and LC are bidentate ligands; LA, LB, and LC are different; ring B is a 5-membered or 6-membered ring; each of X1 to X10 is C or N; ring C is bonded to ring A1 by a C; each RA, RB, and RC is independently hydrogen or a General Substituent; with the exception that no RB can be joined or fused to an RC, any two substituents may be joined or fused to form a ring; and at least two RC substituents are joined together to form a fused ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of Formula I, is provided where moieties B and D are monocyclic or polycyclic rings; M is Pt or Pd; each of X1 to X7, Z1, and Z2 is C or N; Y1 and Y2 are each independently linking groups; L1 and L2 are each independently absent a bond, a direct bond, or a linking group; K is selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?). Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, rings A and B are 5- or 6-membered ring; K1 and K2 are each independently selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); Z1, Z2, X1 and X2 are C or N; Y1*, Y2*, Y3*, Y4*, and Y5* are selected from a variety of moieties; n is 0 or 1; Y5* is bonded directly to X2 when n is 0; each R?, R?, R, R?, R1, R2, RA, and RB is hydrogen or a substituent; each independently represents a single bond or double bond in a Lewis structure; and LA is coordinated to a metal M, which may be coordinated to other ligands. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I is provided. In Formula I, each of moiety A and moiety B is a monocyclic ring or a polycyclic fused ring system; each of Z1 to Z4 is C or N; one of K1 or K2 is a direct bond, and the other is a direct bond or a linker; L is a linker; each R?, R?, R, R?, RA, and RB is a General Substituent defined herein; LA is coordinated to a metal M; and the compound includes at least a silyl group, a germyl group, or an electron-withdrawing group. Formulations, OLEDs, and consumer products containing the same are also provided.

Abstract: A compound having a structure of formula Ir(LA)x(LB)y(LC)z is provided. In Ir(LA)x(LB)y(LC)z, x is 1, 2, or 3; y is 0, 1, or 2; z is 0, 1, or 2; x+y+z=3; LA has a structure of Formula I, and each of LB and LC is independently a bidentate ligand. In Formula I, moiety A is monocyclic ring or a polycyclic fused ring system; moiety B is a fused bicyclic system; Z1, Z2, and Z3 are each C or N; each RA and RB is hydrogen or a General Substituent defined herein; at least one RA or RB includes an electron-withdrawing group; LA is coordinated to Ir through the indicated dashed lines to form a 5-membered chelate ring; and any two substituents may be joined or fused to form a ring.

Abstract: Provided is a compound of Formula of Ir(LA)n(LB)m(LC)o, wherein ligand LA has a structure of Formula I, ligand LB has a structure of Formula II, and LC is a bidentate ligand; and wherein n is 1, or 2; m is 1, or 2; o is 0, or 1; and n+m+o=3; and all the remaining variables are defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, each of X1 to X12 is C or N; Y is a linking group; each RA, RB and RC can be hydrogen or a substituent; at least one RA, RB or RC comprises an electron-withdrawing group; and LA forms a 5-membered chelate ring with an Ir atom via the dashed lines. In addition a number of conditions must be met based on whether or not any pair of RA is joined to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of Ir(LA)m(LB)3-m, having a structure of Formula I, useful as emitters in OLEDs is provided. The variables in Formula I are defined in the present disclosure.

Abstract: An OLED including an anode, a cathode, and an organic layer between the anode and the cathode, where the organic layer includes a compound having the formula [LA]3-nIr[LB]n is disclosed.

Abstract: Provided is a compound having a formula of Ir(LA*)m(LB*)n(LC*)p; wherein each LA, LB, and LC is independently a monoanionic bidentate ligand and different from each other; n and p each is independently 0, 1, or 2; m is 1 or 2; and m+n+p is 3; a free-state of LA has a first triplet energy T1 of EA at 77K; a free-state of LB has a first triplet energy T1 of EB at 77K; a free-state of LC has a first triplet energy T1 of EC at 77K; EA is less than EB and EC whichever EB and EC is present; LA comprises at least one ?-electron deficient electron-withdrawing group; and the compound has an emission spectrum with a FWHM value of no more than 45 nm. Also provided is a compound comprising a first ligand LA having a structure of Formula I, wherein the variables are defined herein.

Abstract: A compound of Ir(LA)m(LB)3-m, having a structure of Formula I, is provided. In Formula I, moieties A and B are each either a monocyclic ring or a polycyclic fused ring system; X1 to X4 and Z1 to Z4 are C or N; Y is a single atom linker, which can be substituted; each R1, R2, R3, R4, and R5 is hydrogen or a General Substituent; m is 1 or 2; at least one of R1, R2, and R3 comprises at least one first electron-withdrawing group; and at least one of R4 and R5 comprises at least one second electron-withdrawing group. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Cyclometalated iridium complexes having triphenylene or aza triphenylene and bulky alkyl substitution that can be used as emitters in OLEDs to improve the external quantum efficiency (EQE) and lifetime of OLEDs are disclosed.

Abstract: Provided are organometallic compounds comprising an at least two-dentate ligand comprising at least one 5-membered or 6-membered carbocyclic or heterocyclic ring. Further provided are organometallic compounds containing a platinum atom as the central metal atom. Also described are their various uses including as emitters in devices such as organic light emitting diodes and related electronic devices. Also provided are formulations comprising these organometallic compounds containing a platinum atom as the central metal atom. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: Provided are compounds compound comprising a first ligand LA of Formula I: wherein R1 and R2 are each independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, germyl, boryl, selenyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein LA is coordinated to a metal M through the indicated dashed lines; wherein M may be coordinated to other ligands; wherein LA may be joined with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and wherein any two substituents may be joined or fused to form a ring. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound having the formula Ir(LA)n(LB)3-n, having the structure of Formula I is provided. In the structure of Formula I, each of A1 through A8 is independently carbon or nitrogen; at least one of A1 through A8 is nitrogen; ring B is bonded to ring A through a C—C bond; the iridium is bonded to ring A through an Ir—C bond; X is O, S, or Se; each of R1 through R5 are independently selected from a variety of substituents, which may be linked for form a ring; n is an integer from 1 to 3; and at least one R2 adjacent to ring C is not hydrogen. Formulations and devices, such as OLEDs, that include the first compound are also provided.

Abstract: Provided are compounds capable of functioning as an emitter in an organic light emitting device at room temperature, and their use in OLED related electronic devices.

Abstract: A compound having a metal coordination complex structure, where the compound is capable of functioning as a phosphorescent emitter in an organic light emitting device at room temperature is disclosed. The compound has a first ligand coordinated to a metal. The free-state of the first ligand has a first triplet energy T1 of EL at 77K, while the compound has a first triplet energy T1 of E at 77K, and the difference in energy (?E) between E and EL is ?250 meV. The compound has a triplet emission spectrum with a FWHM value of no more than 45 nm. Organic light emitting devices, consumer products, and formulations containing the compounds are also disclosed.

Abstract: Indolocarbazole materials with substitution attached at specific positions and methods to synthesize the same are disclosed. The materials are used as hosts for improving performance of organic electroluminescence devices.

Abstract: A compound having a first ligand LA of Formula I useful as phosphorescent dopant in OLEDs is disclosed.